MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$789K
Net Income
$5,696K
Net Profit Margin
721.93%
EPS
$0.64
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Annual
123
Page 1
Income Statement
2025-12-31
Grant revenue
789
Total revenue
789
Research and development expenses
49,060
General and administrative expenses
39,156
Manufacturing services
6,544
Total operating expenses
94,760
Loss from operations
-93,971
Gain on sale of vowst business
80,685
Interest income
2,227
Interest expense
0
Other income (expense), net
16,755
Total other income (expense), net
99,667
Net income (loss) from continuing operations
5,696
Total revenue
0
Research and development expenses
0
General and administrative expenses
0
Collaboration (profit) loss sharing - related party
0
Total operating expenses
0
(loss) income from discontinued operations
0
Gain on sale of vowst business
0
Interest expense
0
Other expense
0
Income (loss) from discontinued operations, pre-tax
0
Income tax
0
Net income from discontinued operations, net of tax
0
Net income (loss)
5,696
Unrealized gain on investments, net of tax of 0
0
Currency translation adjustment
0
Total other comprehensive income
0
Comprehensive income (loss)
5,696
Basic EPS
0.64
Diluted EPS
0.64
Basic Average Shares
8,858,975
Diluted Average Shares
8,869,742
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS).
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Gain on sale of vowst
business
$80,685K
Other income
(expense), net
$16,755K
Interest income
$2,227K
Total other income
(expense), net
$99,667K
Grant revenue
$789K
Net income (loss)
from continuing...
$5,696K
Loss from operations
-$93,971K
Total revenue
$789K
Net income (loss)
$5,696K
Total operating
expenses
$94,760K
Comprehensive income (loss)
$5,696K
Research and development
expenses
$49,060K
General and
administrative expenses
$39,156K
Manufacturing services
$6,544K
Buy us a coffee
Seres Therapeutics, Inc. (MCRB)
Seres Therapeutics, Inc. (MCRB)